Showing results (71-80 of 228) with videos related to

Sort By:
Pageof 23
Experimental & Molecular Medicine|December 17, 2016
Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancerMariette Labots, Kristy J Gotink, Henk Dekker, et al.
Clinical Genitourinary Cancer|February 24, 2015
New Treatment Options for Patients With Metastatic Prostate Cancer: What Is The Optimal Sequence?Joyce M van Dodewaard-de Jong, Henk M W Verheul, Haiko J Bloemendal, et al.
Plos One|June 18, 2016
Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal CancerJohn Pradeep Veluchamy, Jan Spanholtz, Marleen Tordoir, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 25, 2020
Smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase I/II clinical trialsJoeri A J Douma, Sonja Zweegman, Mieke Alberts, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2018
The value of tumour debulking for patients with extensive multi-organ metastatic colorectal cancerElske C Gootjes, Lotte Bakkerus, Albert J Ten Tije, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal CancerSusanne Blauwhoff-Buskermolen, Kathelijn S Versteeg, Marian A E de van der Schueren, et al.
Vaccine|March 10, 2018
A safety and immunogenicity study of immunization with hVEGF<sub>26-104</sub>/RFASE in cynomolgus monkeysMadelon Q Wentink, Henk M W Verheul, Arjan W Griffioen, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 11, 2015
Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanibKristy J Gotink, Maria Rovithi, Richard R de Haas, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 10, 2025
Elacridar improves sunitinib efficacy in colorectal cancer modelsDennis Poel, Kirti K Iyer, Bob van Gasteren, et al.
Urology|August 18, 2009
The relationship of vascular endothelial growth factor and coagulation factor (fibrin and fibrinogen) expression in clear cell renal cell carcinomaHenk M W Verheul, Karen van Erp, Marjolein Y V Homs, et al.
Pageof 23